Stockreport

SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths [Yahoo! Finance]

SELLAS Life Sciences Group, Inc.  (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report
PDF REGAL trial for GPS, a WT1-targeting cancer vaccine in AML patients, approaches completion with 72 of 80 required patient deaths recorded, with only 12 deaths among 66 a [Read more]